Change in circulating adiponectin in advanced old age: Determinants and impact on physical function and mortality. the cardiovascular health study all stars study

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 65 A, Issue 11, 2010, Pages 1208-1214

  Kizer, Jorge R ^a   Arnold, Alice M ^b   Strotmeyer, Elsa S ^c   Ives, Diane G ^c   Cushman, Mary ^d   Ding, Jingzhong ^e   Kritchevsky, Stephen B ^e   Chaves, Paulo H M ^f   Hirsch, Calvin H ^g   Newman, Anne B ^c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adiponectin; Aging; Mortality; Physical Function

Indexed keywords

ADIPONECTIN;

AGE; AGED; AGING; ANALYSIS OF VARIANCE; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; FITNESS; HEALTH STATUS; HUMAN; MALE; METABOLISM; MORTALITY; MULTICENTER STUDY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SEX DIFFERENCE; STATISTICAL MODEL; TIME; UNITED STATES;

ADIPONECTIN; AGE FACTORS; AGED; AGING; ANALYSIS OF VARIANCE; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS; HUMANS; LINEAR MODELS; MALE; PHYSICAL FITNESS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX FACTORS; TIME FACTORS; UNITED STATES;

EID: 77958074658     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glq122     Document Type: Article

References (28)

1. Szmitko PE, Teoh H, Stewart DJ, Verma S. Adiponectin and cardiovascular disease: state of the art? Am J Physiol Heart Circ Physiol. 2007;292:H1655- H1663.
2. Kizer JR, Barzilay JI, Kuller LH, Gottdiener JS. Adiponectin and risk of coronary heart disease in older men and women. J Clin Endocrinol Metab. 2008;93:3357-3364.
3. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004;291:1730-1737.
4. Kistorp C, Faber J, Galatius S, et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation. 2005;112:1756-1762.
5. Dekker JM, Funahashi T, Nijpels G, et al. Prognostic value of adiponectin for cardiovascular disease and mortality. J Clin Endocrinol Metab. 2008;93:1489-1496.
6. Laughlin GA, Barrett-Connor E, May S, Langenberg C. Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. Am J Epidemiol. 2007;165:164-174. (Pubitemid 46096378)
7. Wannamethee SG, Whincup PH, Lennon L, Sattar N. Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure. Arch Intern Med. 2007;167:1510-1517.
8. Poehls J, Wassel CL, Harris TB, et al. Association of adiponectin with mortality in older adults: the Health, Aging, and Body Composition Study. Diabetologia. 2009;52:591-595.
9. Bik W, Baranowska-Bik A, Wolinska-Witort E, et al. The relationship between adiponectin levels and metabolic status in centenarian, early elderly, young and obese women. Neuro Endocrinol Lett. 2006;27:493-500.
10. Adamczak M, Rzepka E, Chudek J, Wiecek A. Ageing and plasma adiponectin concentration in apparently healthy males and females. Clin Endocrinol (Oxf). 2005;62:114-118.
11. Atzmon G, Pollin TI, Crandall J, et al. Adiponectin levels and genotype: a potential regulator of life span in humans. J Gerontol A Biol Sci Med Sci. 2008;63:447-453.
12. Teoh H, Strauss MH, Szmitko PE, Verma S. Adiponectin and myocardial infarction: a paradox or a paradigm? Eur Heart J. 2006;27: 2266-2268.
13. Rathmann W, Herder C. Adiponectin and cardiovascular mortality: evidence for "reverse epidemiology". Horm Metab Res. 2007;39:1-2.
14. Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49:M85-M94.
15. Newman AB, Arnold AM, Sachs MC, et al. Long-term function in an older cohort\-the cardiovascular health study all stars study. J Am Geriatr Soc. 2009;57:432-440.
16. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991;1:263-276.
17. Cushman M, Cornell ES, Howard PR, Bovill EG, Tracy RP Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem. 1995;41:264-270.
18. Macy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem. 1997;43:52-58.
19. Psaty BM, Kuller LH, Bild D, et al. Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Ann Epidemiol. 1995;5:270-277.
20. Ives DG, Fitzpatrick AL, Bild DE, et al. Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann Epidemiol. 1995;5:278-285.
21. Ouchi N, Walsh K. A novel role for adiponectin in the regulation of infammation. Arterioscler Thromb Vasc Biol. 2008;28:1219-1221.
22. TakemuraY, Ouchi N, Shibata R, et al. Adiponectin modulates infammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. J Clin Invest. 2007;117:375-386.
23. Van Berendoncks AM, Garnier A, Beckers P, et al. Functional adiponectin resistance at the level of the skeletal muscle in mild to moderate chronic heart failure. Circ Heart Fail. 2010;3:185-194.
24. Hug C, Wang J, Ahmad NS, Bogan JS, Tsao TS, Lodish HF. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc Natl Acad Sci \USA. 2004;101: 10308-10313.
25. Peake PW, Shen Y, Walther A, Charlesworth JA. Adiponectin binds C1q and activates the classical pathway of complement. Biochem Bio-phys Res Commun. 2008;367:560-565.
26. Ealey KN, Kaludjerovic J, Archer MC, Ward WE. Adiponectin is a negative regulator of bone mineral and bone strength in growing mice. Exp Biol Med (Maywood). 2008;233:1546-1553.
27. Richards JB, Valdes AM, Burling K, Perks UC, Spector TD. Serum adiponectin and bone mineral density in women. J Clin Endocrinol Metab. 2007;92:1517-1523.
28. Pajvani UB, Hawkins M, Combs TP, et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem. 2004; 279:12152-12162.